Conformational regulation of the EGFR kinase core by the juxtamembrane and C‐terminal tail: A molecular dynamics study
暂无分享,去创建一个
[1] J. Kuriyan,et al. The Conformational Plasticity of Protein Kinases , 2002, Cell.
[2] R. Radhakrishnan,et al. Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study. , 2009, Biophysical journal.
[3] J. Schlessinger,et al. Signaling by Receptor Tyrosine Kinases , 1993 .
[4] Nicholas M. Glykos,et al. Software news and updates carma: A molecular dynamics analysis program , 2006, J. Comput. Chem..
[5] G. M. Walton,et al. Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. , 1990, The Journal of biological chemistry.
[6] L. Chin,et al. Mig-6 controls EGFR trafficking and suppresses gliomagenesis , 2010, Proceedings of the National Academy of Sciences.
[7] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[8] Roy S Herbst,et al. Review of epidermal growth factor receptor biology. , 2004, International journal of radiation oncology, biology, physics.
[9] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[10] M. Lamers,et al. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine. , 1999, Journal of molecular biology.
[11] Balazs Halmos,et al. Structure and clinical relevance of the epidermal growth factor receptor in human cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Andrew D. Yates,et al. Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.
[13] Kornelia Polyak,et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex , 1995, Nature.
[14] A. Hinnebusch,et al. Structural Basis for Autoinhibition and Mutational Activation of Eukaryotic Initiation Factor 2α Protein Kinase GCN2*[boxs] , 2005, Journal of Biological Chemistry.
[15] Heather A. Carlson,et al. Development of polyphosphate parameters for use with the AMBER force field , 2003, J. Comput. Chem..
[16] Gennady Verkhivker,et al. Hierarchical Modeling of Activation Mechanisms in the ABL and EGFR Kinase Domains: Thermodynamic and Mechanistic Catalysts of Kinase Activation by Cancer Mutations , 2009, PLoS Comput. Biol..
[17] Ron Bose,et al. Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface , 2007, Nature.
[18] J. Zheng,et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.
[19] Edgar R. Wood,et al. 6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases , 2008, Proceedings of the National Academy of Sciences.
[20] John Kuriyan,et al. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 , 2009, Proceedings of the National Academy of Sciences.
[21] Forest M White,et al. Oncogenic EGFR Signaling Networks in Glioma , 2009, Science Signaling.
[22] Chao Zhang,et al. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. , 2007, Nature chemical biology.
[23] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[24] Fotini Tzortzatou-Stathopoulou,et al. Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation , 2009, Proteins.
[25] Krystal J Alligood,et al. A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) , 2004, Cancer Research.
[26] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[27] Matthew Meyerson,et al. Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. , 2007, Cancer cell.
[28] John Kuriyan,et al. An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor , 2006, Cell.
[29] Ming-Li Xiang,et al. Detailed conformational dynamics of juxtamembrane region and activation loop in c‐Kit kinase activation process , 2008, Proteins.
[30] Andrew F Neuwald,et al. The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module , 2007, Proceedings of the National Academy of Sciences.
[31] M. Sliwkowski,et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. , 2003, Molecular cell.
[32] H. Lane,et al. ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors , 2005, Nature Reviews Cancer.
[33] Anna Maria Almerico,et al. Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors , 2009, Comput. Biol. Chem..
[34] Sarel J Fleishman,et al. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. , 2004, Structure.
[35] N. Xuong,et al. A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. , 1997, Structure.
[36] Ivet Bahar,et al. Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): insights into functional dynamics , 2009, Bioinform..
[37] A. Pozzi,et al. The juxtamembrane region of the EGF receptor functions as an activation domain. , 2009, Molecular cell.
[38] Wei Zhang,et al. A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..
[39] M. Meyerson,et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP , 2008, Proceedings of the National Academy of Sciences.
[40] John Kuriyan,et al. Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment , 2009, Cell.
[41] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.